SnagRx vs LTTL: Compounded GLP-1 pricing, labs, and shipping
Quick verdict: For lowest advertised annual compounded pricing and a named clinician network, SnagRx is the cost-focused option; LTTL emphasizes a first-month discount and lab verification. This article compares SnagRx vs LTTL across pricing, pharmacy and lab practices, dosing and pricing guarantees, shipping and clinician review, and regulatory notes.
How SnagRx vs LTTL differ on headline pricing and commitment
SnagRx lists compounded semaglutide from $69/month and tirzepatide from $119/month as 12-month plan rates; month-to-month equivalents are $99 and $149. SnagRx states those 12-month rates are the annual-plan figures and that the annual plan saves $360 per year compared to month-to-month. LTTL advertises “up to $140 off your first month” with a code auto-applied, and captured landing-page details for ongoing pricing, renewal terms and eligibility were not published or could not be verified on the captured page.
Distinctive point: price lock vs first-month discount
SnagRx highlights a price locked flat at every dose and at renewal so the rate does not rise during titration. LTTL emphasizes an initial discount but the captured evidence warns that pricing, eligibility, pharmacy, state coverage and renewal terms may change.
Pharmacy, lab verification and clinician networks compared
SnagRx names its four US 503A partner pharmacies and says medical care is delivered by OpenLoop Health, a network of US-licensed clinicians covering 48 states. SnagRx states LegitScript certification is claimed and can be verified. LTTL states its compounded GLP-1s are prepared in state-licensed pharmacies and independently verified in FDA-registered labs, and that potency is confirmed every 3–6 months to stay within +/- 10% of target strength, though some captured details were not verifiable on the landing page.
Check LTTL lab verification claim
Distinctive point: named partners vs lab claims
SnagRx provides named 503A partner pharmacies and a named clinician network. LTTL presents claims of independent lab verification and routine potency confirmation but captured landing-page evidence notes current details were not published or could not be verified.
Shipping speed, clinician review, and fulfillment differences
SnagRx states approved orders ship next-day via UPS or FedEx in temperature-controlled packaging and that an OpenLoop clinician typically reviews intake within five hours and always within 24. SnagRx also states declined prescriptions are refunded in full. LTTL says medication is delivered to your door when needed and is compounded by U.S. licensed pharmacies; the captured page emphasizes delivery and verification but does not include the same specific clinician review or next-day shipping timeline captured for SnagRx.
Compounding and regulatory notes both providers share
Both providers offer compounded GLP-1 medications and the captured materials include the same regulatory reminder: compounded medications are not FDA-approved finished products and are not reviewed by the FDA for safety, effectiveness or quality. SnagRx repeats that compounded medications are produced in FDA-regulated facilities but are not FDA-approved; LTTL also notes that compounded medications, when offered, are not FDA-approved.
Comparison table: 7 criteria at a glance
| Criteria | SnagRx | LTTL |
|---|---|---|
| Starting price captured | Semaglutide from $69/mo on 12-month plan; month-to-month $99 | Captured: up to $140 off first month; other pricing details not verified |
| Price during titration | Price locked flat at every dose and at renewal | Claim: Same price every dose; details not fully published |
| Pharmacies and labs | Names four US 503A partner pharmacies; states LegitScript certification | Compounded by U.S. licensed pharmacies; claims independent lab verification |
| Clinician network | OpenLoop Health network, covers 48 states | Treatment available only when licensed clinician determines medically appropriate; coverage details not published |
| Shipping and fulfillment | Next-day UPS/FedEx in temperature-controlled packaging; clinician review typically within 5 hours | Delivered to your door; captured page emphasizes delivery timing but lacks specific next-day claim |
| Refunds/declines | Full refund if prescription declined; 6-month weight-loss guarantee (terms apply) | Captured page did not publish specific refund policy details |
| Regulatory note | Compounded medications are not FDA-approved | Compounded medications are not FDA-approved |
How dosing, coaching, and extras compare
SnagRx explicitly states it provides compounded semaglutide and tirzepatide plus prescription and telemed visits included, but also states there is no coaching or nutrition programming. SnagRx advertises a 6-month weight-loss guarantee with terms. LTTL emphasizes full-dose GLP-1 and appetite regulation language; captured content does not show coaching, nutrition programming, or guarantee details, and many long-bullet specifics were not verifiable on the captured affiliate landing page.
Compare SnagRx treatment details
Final take on SnagRx vs LTTL
SnagRx is the clearer choice if you prioritize an advertised low annual plan price, a named clinician network, named 503A pharmacies, next-day shipping claims and a stated price lock across titration. LTTL presents a first-month discount and lab verification claims but the captured landing-page evidence did not publish or verify ongoing pricing, renewal and state-coverage details fully.
Choose SnagRx if…
You want bottom-of-market annual pricing for compounded semaglutide or tirzepatide with a price locked at every dose, named US 503A partner pharmacies, an OpenLoop clinician network and stated next-day temperature-controlled shipping.
Choose LTTL if…
You prefer an advertised first-month discount and claims of independent lab verification and routine potency confirmation, and you will confirm eligibility, pricing, pharmacy and renewal terms with LTTL before enrolling.